Search research articles
Contact Us
Filters
Showing results (171-180 of 205) with videos related to
Page
of 21
Sort By:
Biological Psychiatry
|
June 14, 2005
Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants
Andrew A Nierenberg, Sachiko Miyahara, Tom Spencer, et al.
Depression and Anxiety
|
September 17, 2013
Sleep quality predicts treatment outcome in CBT for social anxiety disorder
Alyson K Zalta, Sheila Dowd, David Rosenfield, et al.
Depression and Anxiety
|
June 18, 2016
RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER
Michael W Otto, Mark H Pollack, Sheila M Dowd, et al.
Biological Psychiatry
|
October 9, 2009
Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder
Michael W Otto, David F Tolin, Naomi M Simon, et al.
European Journal of Psychotraumatology
|
October 8, 2020
Maintenance of treatment gains up to 12-months following a three-week cognitive processing therapy-based intensive PTSD treatment programme for veterans
Philip Held, Alyson K Zalta, Dale L Smith, et al.
Archives of General Psychiatry
|
September 7, 2005
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam
Karl Rickels, Mark H Pollack, Douglas E Feltner, et al.
BMC Psychiatry
|
December 16, 2022
Protocol for a multi-site randomized controlled trial of a stepped-care intervention for emergency department patients with panic-related anxiety
Sharon C Sung, Leslie Lim, Swee Han Lim, et al.
Psychological Trauma : Theory, Research, Practice and Policy
|
July 19, 2019
Feasibility of a 3-week intensive treatment program for service members and veterans with PTSD
Philip Held, Brian J Klassen, Randy A Boley, et al.
European Journal of Psychotraumatology
|
May 28, 2025
Exploring study dropout in drug trials for adults with PTSD: insights from a conventional and individual participant data meta-analysis
Simonne L Wright, Anna Kessler, Marit Sijbrandij, et al.
Biological Psychiatry
|
November 2, 2015
Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions
Michael W Otto, M Alexandra Kredlow, Jasper A J Smits, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 205) with videos related to
Sort By:
Page
of 21
Biological Psychiatry
|
June 14, 2005
Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants
Andrew A Nierenberg, Sachiko Miyahara, Tom Spencer, et al.
Depression and Anxiety
|
September 17, 2013
Sleep quality predicts treatment outcome in CBT for social anxiety disorder
Alyson K Zalta, Sheila Dowd, David Rosenfield, et al.
Depression and Anxiety
|
June 18, 2016
RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER
Michael W Otto, Mark H Pollack, Sheila M Dowd, et al.
Biological Psychiatry
|
October 9, 2009
Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder
Michael W Otto, David F Tolin, Naomi M Simon, et al.
European Journal of Psychotraumatology
|
October 8, 2020
Maintenance of treatment gains up to 12-months following a three-week cognitive processing therapy-based intensive PTSD treatment programme for veterans
Philip Held, Alyson K Zalta, Dale L Smith, et al.
Archives of General Psychiatry
|
September 7, 2005
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam
Karl Rickels, Mark H Pollack, Douglas E Feltner, et al.
BMC Psychiatry
|
December 16, 2022
Protocol for a multi-site randomized controlled trial of a stepped-care intervention for emergency department patients with panic-related anxiety
Sharon C Sung, Leslie Lim, Swee Han Lim, et al.
Psychological Trauma : Theory, Research, Practice and Policy
|
July 19, 2019
Feasibility of a 3-week intensive treatment program for service members and veterans with PTSD
Philip Held, Brian J Klassen, Randy A Boley, et al.
European Journal of Psychotraumatology
|
May 28, 2025
Exploring study dropout in drug trials for adults with PTSD: insights from a conventional and individual participant data meta-analysis
Simonne L Wright, Anna Kessler, Marit Sijbrandij, et al.
Biological Psychiatry
|
November 2, 2015
Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions
Michael W Otto, M Alexandra Kredlow, Jasper A J Smits, et al.
Page
of 21